Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Adverse Event Reporting
Login
menu
Home
Active Ingredients
Durvalumab
Durvalumab
Medicine
Status
PIL
SPC
XPIL
Legal Category
Active Ingredient(s)
Company
IMFINZI 50 mg/mL concentrate for solution for infusion
Updated
PIL
04/05/23
SPC
08/05/23
No
A
Durvalumab
AstraZeneca Pharmaceuticals (Ireland) DAC
Direct Healthcare Professional Communications
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
